Hexagon Capital Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-19
Closed -$2.6K 261
2025
Q1
$2.6K Sell
19
-18
-49% -$2.57K ﹤0.01% 1333
2024
Q4
$5.66K Sell
37
-7
-16% -$1.18K ﹤0.01% 1174
2024
Q3
$8.53K Sell
44
-1
-2% -$209 ﹤0.01% 961
2024
Q2
$10.4K Sell
45
-6
-12% -$1.3K ﹤0.01% 865
2024
Q1
$11K Sell
51
-67
-57% -$15.7K ﹤0.01% 837
2023
Q4
$30.5K Buy
118
+51
+76% +$12.5K 0.01% 523
2023
Q3
$17.2K Sell
67
-24
-26% -$6.42K ﹤0.01% 597
2023
Q2
$25.9K Buy
91
+3
+3% +$893 0.01% 497
2023
Q1
$24.5K Sell
88
-8
-8% -$2.21K 0.01% 495
2022
Q4
$26.6K Sell
96
-89
-48% -$25.1K 0.01% 475
2022
Q3
$49K Sell
185
-34
-16% -$7.22K 0.01% 391
2022
Q2
$45K Buy
219
+50
+30% +$10.2K 0.01% 383
2022
Q1
$36K Sell
169
-8
-5% -$1.74K 0.01% 412
2021
Q4
$42K Hold
177
0.01% 385
2021
Q3
$50K Hold
177
0.01% 345
2021
Q2
$61K Hold
177
0.02% 301
2021
Q1
$49K Hold
177
0.01% 309
2020
Q4
$43K Hold
177
0.01% 284
2020
Q3
$44K Buy
+177
New +$49.4K 0.01% 269

Other funds holding BIIB